| Oct 17 |
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
|
| Oct 16 |
Lilly, Gilead, Amgen started at outperform by Bernstein
|
| Oct 15 |
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts
|
| Oct 14 |
How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket
|
| Oct 10 |
Is Gilead Sciences, Inc. (NASDAQ:GILD) The Most Popular Stock Among Mutual Funds According To Goldman Sachs?
|
| Oct 9 |
Gilead Sciences Inc (GILD) Q2 2024 Earnings Call Highlights: Strong Growth in HIV and Oncology ...
|
| Oct 9 |
Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
|
| Oct 9 |
Gilead to Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline and HIV Leadership at IDWeek 2024
|
| Oct 8 |
Gilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know
|
| Oct 7 |
Gilead Presents Additional Efficacy, Safety and Demographic Data From PURPOSE 2 Trial at 5th HIV Research for Prevention Conference
|
